Registry for patients with spinal tumors undergoing surgery
Swiss Spinal Tumor Registry (Swiss-STR)
This study is collecting information from patients who have surgery for spinal tumors to see how well different treatments work and to improve care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Luzerner Kantonsspital Academic / other |
| Locations | 1 site (Lucerne, Canton of Lucerne) |
| Trial ID | NCT06869746 on ClinicalTrials.gov |
What this trial studies
The Swiss Spinal Tumor Registry is a prospective registry that collects data on patients who have undergone surgical treatment for primary and metastatic spinal tumors. It aims to address the lack of robust clinical outcomes data by documenting various surgical interventions and their effectiveness. The registry will categorize clinical presentations of spinal tumors to inform treatment recommendations and assess the socio-economic impact of these conditions on healthcare. By gathering comprehensive data, the study seeks to improve the quality of care for patients with spinal tumors.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with either primary or metastatic spinal tumors who are indicated for surgical treatment.
Not a fit: Patients under 18 years old or those who withdraw consent or from the planned surgical procedure may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment guidelines and better patient outcomes for those with spinal tumors.
How similar studies have performed: Other registries and studies focusing on surgical outcomes for spinal tumors have shown promise in improving treatment protocols and patient care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of primary spinal tumor * Diagnosis of secondary (metastatic) spinal tumor * Indication for surgical treatment is present * Patient age: =/\>18 years Exclusion criteria: * Withdrawal of consent * Withdrawal from initially planned surgical procedure * Patient age: \<18 years
Where this trial is running
Lucerne, Canton of Lucerne
- Lucerne Cantonal Hospital — Lucerne, Canton of Lucerne, Switzerland (Recruiting)
Study contacts
- Principal investigator: Edin Nevzati, MD
- Study coordinator: Edin Nevzati, MD
- Email: edin.nevzati@luks.ch
- Phone: +41412054504
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.